ClinicalTrials.gov
ClinicalTrials.gov Menu

Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01653431
Recruitment Status : Recruiting
First Posted : July 31, 2012
Last Update Posted : March 20, 2018
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales

Brief Summary:
The study will examine whether the effects of computerized brain training are enhanced when training is combined with mild brain stimulation in patients with mild cognitive impairment. We hypothesize that this combination will produce greater improvements in cognitive functioning than computerized brain training alone.

Condition or disease Intervention/treatment Phase
Mild Cognitive Impairment Device: Transcranial direct current stimulation Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 76 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : January 2013
Estimated Primary Completion Date : July 2018

Arm Intervention/treatment
Experimental: Transcranial direct current stimulation
Transcranial direct current stimulation combined with cognitive training
Device: Transcranial direct current stimulation
Sham Comparator: Sham transcranial direct current stimulation
Sham transcranial direct current stimulation combined with cognitive training
Device: Transcranial direct current stimulation



Primary Outcome Measures :
  1. California Verbal Learning Test II [ Time Frame: Post treatment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Aged 60 - 85 years.
  • Meet diagnostic criteria for amnestic mild cognitive impairment.

Exclusion Criteria:

  • Inability to provide informed consent.
  • Concurrent medication likely to affect mental performance.
  • Current substance use or dependence in last 3 months.
  • Current active psychiatric or neurological condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01653431


Contacts
Contact: Donel M Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au

Locations
Australia, New South Wales
Black Dog Institute Recruiting
Sydney, New South Wales, Australia, 2031
Sub-Investigator: Donel M Martin, PhD         
Sponsors and Collaborators
The University of New South Wales

Responsible Party: Melissa Pigot, Research Assistant, The University of New South Wales
ClinicalTrials.gov Identifier: NCT01653431     History of Changes
Other Study ID Numbers: HC12381
First Posted: July 31, 2012    Key Record Dates
Last Update Posted: March 20, 2018
Last Verified: March 2018

Additional relevant MeSH terms:
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders